WVE-004
- Generic Name
- WVE-004
Open-label Extension (OLE) Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) and/or Frontotemporal Dementia (FTD)
- First Posted Date
- 2023-01-13
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Wave Life Sciences Ltd.
- Target Recruit Count
- 8
- Registration Number
- NCT05683860
- Locations
- 🇳🇱
Erasmus MC, Rotterdam, Netherlands
🇳🇱Universitair Medisch Centrum Utrecht, Utrecht, Netherlands
🇬🇧University of Oxford - Nuffield Department of Clinical Neurosciences, Oxford, United Kingdom
Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)
- First Posted Date
- 2021-06-18
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Wave Life Sciences Ltd.
- Target Recruit Count
- 35
- Registration Number
- NCT04931862
- Locations
- 🇦🇺
Perron Institute, Nedlands, Western Australia, Australia
🇳🇱Erasmus University MC, Rotterdam, Netherlands
🇨🇦McGill University Health Center - Research Institute, Montréal, Quebec, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath